ArticleBMC infectious diseases2026
Clinical profiles of patients with antibiotic-resistant infections at select tertiary hospitals in Uganda: a retrospective study of clinical records.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntibiotic resistance (ABR) remains a critical global health threat, with disproportionate burden in low-resource settings.
methodsThis retrospective study analyzed the clinical records of 599 patients across nine Uganda tertiary hospitals between March 2023 and April 2024. We described ABR rates and used multivariable mixed effects modified Poisson regression to determine the factors associated with ABR. We defined non-multidrug-resistance (non-MDR) as resistance to less than three antibiotic classes, MDR as resistance to at least three antibiotic classes, extremely drug-resistance (XDR) as resistance to at least one antibiotic in all but two or less antibiotic classes and pan drug resistance (PDR) as resistance to all antibiotics classes.
resultsThe 325 samples from patients with culture confirmed infections yielded 378 pathogens. Of the pathogens tested against three or more antibiotic classes (362), 126/362 (34.8%) were non-MDR and 236/362 (65.2%) MDR. Among the MDR, 165 (47.3%) were XDR, and 18 (5.2%) PDR. The prevalence of ABR was highest on surgical 168 (92%), maternity 30 (91%), and ICU 24 (89%) wards. Regression analysis identified ward type as a key predictor: surgical and "other" wards (gynecology, private, and orthopedic) had a 22% (PR, 1.22, 95% CI 1.09-1.37, p < 0.001) and 26% (PR, 1.26, 95% CI 1.05-1.52 p = 0.016) higher ABR risks, respectively. Antibiotics prescription on admission was associated with a reduced risk for ABR while age, sex, referral status, and Human Immunodeficiency Virus status were not associated with ABR. Overall ABR associated mortality was 12.7%, higher among inpatients admitted for shorter hospital days (median 8 vs. 20 days, p < 0.001), intubated patients, and those admitted to the ICU. Patients with resistance stayed in the hospital five days longer than those with no resistance. Escherichia coli, Klebsiella spp. and Staphylococcus aureus, the most isolated pathogens, were highly resistant to commonly used antibiotics, including extended-spectrum beta-lactamase (ESBL) and methicillin-resistant Staphylococcus aureus (MRSA) phenotypes.
conclusionThese findings highlight the clinical impact of ABR in Uganda, especially in high-risk wards such as the ICU and among intubated patients. Strategies for strengthening antibiotic stewardship, infection prevention and diagnostics to combat ABR in Uganda are urgently needed. TRAIL REGISTRATION: N/A.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.